Published in AIDS Weekly, May 5th, 1997
The contract is for a three-year basic term with two one-year extension options, with total estimated revenues to the company of approximately $2 million. The results of the studies conducted by the company are used to provide NCI investigators with information regarding the proper storage and handling of various drug products under investigation and to support NCI's Investigational New Drug Applications filed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.